Uriach-Aquilea OTC SL in Consumer Health (Spain)

July 2013 | 2 pages | ID: U784F9B2FFEEN
Euromonitor International Ltd

Abstracts

The strategic direction of the Spanish company Uriach-Aquilea did not change in 2012. It was still focusing on its expansion at an international level. After creating a joint-venture with a Chinese company under the name Sunlight Pharmaceutical in 2012, the company focused on entering the North American market. In 2012 it received approval from the FDA to commercialise its products in the US.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Uriach-Aquilea OTC SL: Key Facts
Summary 2 Uriach-Aquilea OTC SL: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Uriach-Aquilea OTC SL: Competitive Position 2012